glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Tested Reactivity Anti-GLP-1 antibody [EPR4042-1] (ab108443) |
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Tested Reactivity Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://content.abcam.com/products/images/glp-1-antibody-epr4042-1-ab108443--immunocytochemistry-immunofluorescence-img108423.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Tested Reactivity Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://content.abcam.com/products/images/glp-1-antibody-11e2-ab23468--immunocytochemistry-immunofluorescence-img63062.jpg)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Tested Reactivity Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://7tmantibodies.com/media/image/0e/a7/16/GLP1-IHC-F1.png)
![glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites Tested Reactivity Anti-GLP-1 antibody [EPR4042-1] (ab108443) |](https://www.thermofisher.com/antibody/images/150/710320_WB.jpg?time=20220826)


















